Category: Emerging Infectious Diseases
Wild ducks found dead in Maine test positive for bird flu
(Maine News) Wildlife authorities in Maine said six wild ducks found dead in a stream in Winthrop have tested positive for bird flu. The hooded mergansers were found dead in Mill Stream and tested positive for a highly pathogenic avian influenza, the Maine Department of Inland Fisheries and Wildlife said Friday. The wildlife department said […]
Feb 14, 2023
Avian Flu hits migratory birds in north Louisiana(
(KTBS) The H5N1 Avian Flu is not just affecting poultry on farms. The virus has spread to migratory water fowl, and there are infected birds in north Louisiana. According to the Louisiana Department of Wildlife and Fisheries, several geese that died from the flu were discovered in late November. In September, the virus was also found […]
Feb 14, 2023
As bird flu spreads to minks, sea lions and other mammals, scientists are on alert for dangerous mutations
(NBC News) Adapted to birds, H5N1 has been found in various mammals, but it would need a complicated string of mutations to spread more easily in people. Hundreds of wild sea lions in South America, a farm of minks in Europe, and more than 58 million poultry birds have died. All of these animals fell victim to the impact of […]
Feb 14, 2023
NCDC Records 117 Lassa Fever Outbreak In 13 States, FCT
(Science Nigeria) The Nigeria Centre for Disease Control and Prevention (NCDC) said it has recorded 117 additional Lassa fever cases from 13 states and the Federal Capital Territory (FCT) in the reporting week 4. Disclosing this via its official website today (February 13, 2023), the NCDC said the 13 states include Ondo, Edo, Taraba, Bauchi, Ebonyi, […]
Feb 14, 2023
NCDC reports 763 Monkeypox cases, as Lassa fever kills 53 in January
(The Nation) Nigeria has recorded 763 (501 male, 261 female) confirmed cases of Monkeypox diseases from 34 states and Federal Capital Territory (FCT), as of January 1, 2023, according to the latest epidemiological data from the Nigeria Centre for Disease Control and Prevention (NCDC). Of the states with the cases of Monkeypox in the country, […]
Feb 14, 2023
COVID Rebound Can Happen Even without Paxlovid
(Scientific American) Concerns about Paxlovid rebound are preventing some doctors from prescribing the lifesaving drug and some high-risk patients from taking it. Paxlovid gets a bad rap over concerns about COVID “rebound.” That’s the primary takeaway from a series of papers showing that whether or not people take the antiviral medication, many have symptoms that […]
Feb 14, 2023
Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments
(Scientific American) The causes of long COVID, which disables millions, may come together in the brain and nervous system. Tara Ghormley has always been an overachiever. She finished at the top of her class in high school, graduated summa cum laude from college and earned top honors in veterinary school. She went on to complete […]
Feb 14, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
(The Lancet) WHO has identified Marburg virus as an emerging virus requiring urgent vaccine research and development, particularly due to its recent emergence in Ghana. We report results from a first-in-human clinical trial evaluating a replication-deficient recombinant chimpanzee adenovirus type 3 (cAd3)-vectored vaccine encoding a wild-type Marburg virus Angola glycoprotein (cAd3-Marburg) in healthy adults.
Feb 14, 2023
Marburg vaccine shows promising results in first-in-human study
(NIH) A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, could someday be an important tool […]
Feb 14, 2023
The Future of Long COVID
(Atlantic) In the early spring of 2020, the condition we now call long COVID didn’t have a name, much less a large community of patient advocates. For the most part, clinicians dismissed its symptoms, and researchers focused on SARS-CoV-2 infections’ short-term effects. Now, as the pandemic approaches the end of its third winter in the […]
Feb 14, 2023